B

BioNote Inc
KRX:377740

Watchlist Manager
BioNote Inc
KRX:377740
Watchlist
Price: 4 860 KRW 1.89% Market Closed
Market Cap: 495.6B KRW
Have any thoughts about
BioNote Inc?
Write Note

BioNote Inc
Other Items

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

BioNote Inc
Other Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Items CAGR 3Y CAGR 5Y CAGR 10Y
B
BioNote Inc
KRX:377740
Other Items
-â‚©477B
CAGR 3-Years
-78%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Other Items
â‚©394.6B
CAGR 3-Years
N/A
CAGR 5-Years
23%
CAGR 10-Years
N/A
SK Bioscience Co Ltd
KRX:302440
Other Items
â‚©5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Other Items
â‚©131.1B
CAGR 3-Years
N/A
CAGR 5-Years
-3%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Other Items
-â‚©24.4B
CAGR 3-Years
-24%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Other Items
-â‚©16.1B
CAGR 3-Years
49%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

BioNote Inc
Glance View

Market Cap
496B KRW
Industry
Biotechnology

BioNote, Inc. develops veterinary diagnostic composition. The company is headquartered in Hwaseong, Gyeonggi-Do. The company went IPO on 2022-12-22. The firm is engaged in the manufacture and sale of rapid diagnostic kits for humans, diagnosis raw materials such as antigens, antibody cell lines, standards, enzymes and others as well as semi-finished products. The firm is also engaged in the manufacture and sale of rapid immunochemical diagnosis, enzyme immune rebound protein, immunochemical fluorescence diagnosis and other products used for animals.

Intrinsic Value
4 469.88 KRW
Overvaluation 8%
Intrinsic Value
Price
B

See Also

What is BioNote Inc's Other Items?
Other Items
-477B KRW

Based on the financial report for Dec 31, 2023, BioNote Inc's Other Items amounts to -477B KRW.

What is BioNote Inc's Other Items growth rate?
Other Items CAGR 3Y
-78%

The average annual Other Items growth rates for BioNote Inc have been -78% over the past three years .

Back to Top